Research Analysts Offer Predictions for CLMT FY2026 Earnings

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMTFree Report) – Equities researchers at HC Wainwright lowered their FY2026 earnings per share estimates for shares of Calumet Specialty Products Partners in a research report issued on Monday, November 11th. HC Wainwright analyst A. Dayal now expects that the oil and gas company will post earnings per share of $1.86 for the year, down from their previous estimate of $1.89. HC Wainwright currently has a “Buy” rating and a $25.00 target price on the stock. The consensus estimate for Calumet Specialty Products Partners’ current full-year earnings is ($2.02) per share. HC Wainwright also issued estimates for Calumet Specialty Products Partners’ FY2027 earnings at $2.40 EPS and FY2028 earnings at $2.68 EPS.

Calumet Specialty Products Partners (NASDAQ:CLMTGet Free Report) last released its quarterly earnings data on Friday, November 8th. The oil and gas company reported ($1.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.59) by ($0.59). The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $888.36 million. Calumet Specialty Products Partners’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.03 earnings per share.

CLMT has been the topic of a number of other research reports. Wells Fargo & Company raised their target price on shares of Calumet Specialty Products Partners from $25.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. TD Cowen reduced their price objective on Calumet Specialty Products Partners from $27.00 to $26.00 and set a “buy” rating for the company in a research report on Monday. StockNews.com began coverage on Calumet Specialty Products Partners in a research report on Wednesday, October 23rd. They issued a “sell” rating on the stock. Finally, The Goldman Sachs Group cut their target price on Calumet Specialty Products Partners from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Monday, August 5th. One analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $23.75.

Check Out Our Latest Report on Calumet Specialty Products Partners

Calumet Specialty Products Partners Stock Performance

NASDAQ CLMT opened at $19.90 on Wednesday. Calumet Specialty Products Partners has a one year low of $9.97 and a one year high of $25.29. The company has a 50-day simple moving average of $19.44 and a 200-day simple moving average of $17.06. The firm has a market capitalization of $1.71 billion, a PE ratio of -7.21 and a beta of 1.90.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Wasserstein Debt Opportunities Management L.P. raised its stake in shares of Calumet Specialty Products Partners by 2.9% during the second quarter. Wasserstein Debt Opportunities Management L.P. now owns 6,891,314 shares of the oil and gas company’s stock valued at $110,606,000 after purchasing an additional 193,063 shares in the last quarter. Raymond James & Associates raised its position in shares of Calumet Specialty Products Partners by 13.4% during the 2nd quarter. Raymond James & Associates now owns 572,057 shares of the oil and gas company’s stock worth $9,182,000 after buying an additional 67,689 shares in the last quarter. DRW Securities LLC acquired a new stake in shares of Calumet Specialty Products Partners in the 2nd quarter worth approximately $898,000. Creative Planning boosted its holdings in shares of Calumet Specialty Products Partners by 46.4% in the second quarter. Creative Planning now owns 62,459 shares of the oil and gas company’s stock valued at $1,002,000 after acquiring an additional 19,800 shares in the last quarter. Finally, Wedbush Securities Inc. bought a new position in shares of Calumet Specialty Products Partners in the second quarter valued at approximately $169,000. Institutional investors own 34.41% of the company’s stock.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.

See Also

Earnings History and Estimates for Calumet Specialty Products Partners (NASDAQ:CLMT)

Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.